NYSE:IVC - Invacare Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Invacare Co. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $9.20 +0.38 (+4.31 %) (As of 12/8/2019 10:40 AM ET) Add Compare Today's Range$8.84Now: $9.20▼$9.2650-Day Range$6.01MA: $8.57▼$11.0052-Week Range$3.05Now: $9.20▼$11.63Volume454,117 shsAverage Volume489,240 shsMarket Capitalization$309.67 millionP/E RatioN/ADividend Yield0.57%Beta2.03 ProfileAnalyst RatingsAdvanced ChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through Europe, North America/Home Medical Equipment, Institutional Products Group, and the Asia/Pacific segments. It offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products. Read More… Industry, Sector and Symbol Stock Exchange NYSE Industry Surgical appliances & supplies Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNYSE:IVC Previous Symbol CUSIP46120310 CIK742112 Webhttp://www.invacare.com/ Phone440-329-6000Debt Debt-to-Equity Ratio0.83 Current Ratio1.76 Quick Ratio1.16Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$972.35 million Price / Sales0.32 Cash FlowN/A Price / Cash FlowN/A Book Value$9.70 per share Price / Book0.95Profitability EPS (Most Recent Fiscal Year)($1.32) Net Income$-43,920,000.00 Net Margins-3.82% Return on Equity-9.30% Return on Assets-3.60%Miscellaneous Employees4,200 Outstanding Shares33,660,000Market Cap$309.67 million Next Earnings Date2/12/2020 (Estimated) OptionableOptionable Receive IVC News and Ratings via Email Sign-up to receive the latest news and ratings for IVC and its competitors with MarketBeat's FREE daily newsletter. IVC Rates by TradingView Invacare (NYSE:IVC) Frequently Asked Questions What is Invacare's stock symbol? Invacare trades on the New York Stock Exchange (NYSE) under the ticker symbol "IVC." How often does Invacare pay dividends? What is the dividend yield for Invacare? Invacare declared a quarterly dividend on Thursday, November 21st. Shareholders of record on Friday, January 3rd will be paid a dividend of $0.0125 per share on Friday, January 17th. This represents a $0.05 annualized dividend and a yield of 0.54%. The ex-dividend date is Thursday, January 2nd. View Invacare's Dividend History. How were Invacare's earnings last quarter? Invacare Co. (NYSE:IVC) released its quarterly earnings data on Wednesday, November, 6th. The health services provider reported ($0.15) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.20) by $0.05. The health services provider earned $235.80 million during the quarter, compared to analyst estimates of $244.81 million. Invacare had a negative return on equity of 9.30% and a negative net margin of 3.82%. Invacare's revenue for the quarter was down 3.6% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.40) EPS. View Invacare's Earnings History. When is Invacare's next earnings date? Invacare is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Invacare. What price target have analysts set for IVC? 1 brokers have issued 1-year price objectives for Invacare's shares. Their forecasts range from $15.00 to $15.00. On average, they expect Invacare's share price to reach $15.00 in the next year. This suggests a possible upside of 63.0% from the stock's current price. View Analyst Price Targets for Invacare. What is the consensus analysts' recommendation for Invacare? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Invacare in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Invacare. Has Invacare been receiving favorable news coverage? News headlines about IVC stock have trended very negative this week, InfoTrie reports. InfoTrie rates the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Invacare earned a media sentiment score of -3.0 on InfoTrie's scale. They also gave media stories about the health services provider a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Invacare. Who are some of Invacare's key competitors? Some companies that are related to Invacare include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Hologic (HOLX), Steris (STE) and Varian Medical Systems (VAR). What other stocks do shareholders of Invacare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Invacare investors own include ImmunoGen (IMGN), Opko Health (OPK), ResMed (RMD), Catalyst Pharmaceuticals (CPRX), Immunomedics (IMMU), Lexicon Pharmaceuticals (LXRX), TherapeuticsMD (TXMD), Chesapeake Energy (CHK), NovaBay Pharmaceuticals (NBY) and Abeona Therapeutics (ABEO). Who are Invacare's key executives? Invacare's management team includes the folowing people: Mr. Matthew E. Monaghan, Chairman, Pres & CEO (Age 51)Ms. Kathleen P. Leneghan, Sr. VP & CFO (Age 56)Mr. Anthony C. LaPlaca, Sr. VP, Gen. Counsel & Sec. (Age 61)Ms. Darcie L. Karol, Sr. VP of HR (Age 52)Mr. Ralf A. Ledda, Sr. VP & GM of EMEA (Age 51) Who are Invacare's major shareholders? Invacare's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Millennium Management LLC (7.54%), Krensavage Asset Management LLC (3.64%), State Street Corp (3.38%), Granahan Investment Management Inc. MA (1.68%), Keeley Teton Advisors LLC (0.92%) and Stephens Inc. AR (0.87%). Company insiders that own Invacare stock include Anthony Laplaca, Baiju R Shah, C Martin Harris, Clifford D Nastas, Dean J Childers, Kathleen P Leneghan and Matthew E Monaghan. View Institutional Ownership Trends for Invacare. Which institutional investors are selling Invacare stock? IVC stock was sold by a variety of institutional investors in the last quarter, including Krensavage Asset Management LLC, Squarepoint Ops LLC, Keeley Teton Advisors LLC, Essex Investment Management Co. LLC, Granahan Investment Management Inc. MA, Adirondack Research & Management Inc. and Nisa Investment Advisors LLC. View Insider Buying and Selling for Invacare. Which institutional investors are buying Invacare stock? IVC stock was acquired by a variety of institutional investors in the last quarter, including Millennium Management LLC, Stephens Inc. AR, Mackay Shields LLC, Dupont Capital Management Corp, Voya Investment Management LLC, BBVA USA Bancshares Inc., State Street Corp and State of Alaska Department of Revenue. Company insiders that have bought Invacare stock in the last two years include Clifford D Nastas, Kathleen P Leneghan and Matthew E Monaghan. View Insider Buying and Selling for Invacare. How do I buy shares of Invacare? Shares of IVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Invacare's stock price today? One share of IVC stock can currently be purchased for approximately $9.20. How big of a company is Invacare? Invacare has a market capitalization of $309.67 million and generates $972.35 million in revenue each year. The health services provider earns $-43,920,000.00 in net income (profit) each year or ($1.32) on an earnings per share basis. Invacare employs 4,200 workers across the globe.View Additional Information About Invacare. What is Invacare's official website? The official website for Invacare is http://www.invacare.com/. How can I contact Invacare? Invacare's mailing address is ONE INVACARE WAY, ELYRIA OH, 44035. The health services provider can be reached via phone at 440-329-6000 or via email at [email protected] MarketBeat Community Rating for Invacare (NYSE IVC)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 226 (Vote Outperform)Underperform Votes: 267 (Vote Underperform)Total Votes: 493MarketBeat's community ratings are surveys of what our community members think about Invacare and other stocks. Vote "Outperform" if you believe IVC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IVC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/8/2019 by MarketBeat.com StaffFeatured Article: Does the discount rate affect the economy?